Clinical Trial Update: Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial results for brexpiprazole in treating irritability associated with autism spectrum disorder in children and adolescents have been posted. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Irritability Associated With Autism Spectrum Disorder (ASD) | Phase 3 | Status: COMPLETED | Results posted: 2025-08-28